Package leaflet

TRICORTIN 1000 12 mg+1mg/2 ml injectable solution for intramuscular use

Cerebral cortex phospholipids + cyanocobalamin
COMPOSITION
Active substances:
Cerebral cortex phospholipids 12 mg
Cyanocobalamin 1000 mcg
Excipients:
Hydrochloride lidocaine - disodium phosphate 12H O - monosodium phosphate 2H O - esters of p-hydroxybenzoic
acid - water for injections q.s. to 2 ml
PHARMACEUTICAL FORM
Injectable solution for intramuscular use.
5 vials of 2 ml
THERAPEUTIC PHARMACOLOGICAL CATEGORY
Psycholeptics - other psychostimulants and nootropics - combinations.
MARKETING AUTHORISATION HOLDER AND MANUFACTURER
Fidia Farmaceutici S.p.A. - Via Ponte della Fabbrica, 3/A - 35031 Abano Terme (PD)
THERAPEUTIC INDICATIONS
Polyalgic-neurotic syndromes
CONTRAINDICATIONS
Hypersensitivity to the components of the product and to other substances closely related from a chemical
standpoint.
PRECAUTIONS FOR USE
The drug does not require special precautions for use.
INTERACTIONS
No interactions between TRICORTIN 1000 and other drugs have been reported.
WARNINGS
The drug may be administered during pregnancy and lactation under direct medical supervision. The drug does not interfere with the ability to drive or operate machinery.
DOSAGE, METHOD AND TIMES OF ADMINISTRATION
1 vial per day by intramuscular route, as prescribed by a physician.
OVERDOSAGE
No symptoms of overdose have ever been observed at the recommended doses.
UNDESIRABLE EFFECTS
To date, no adverse effects related to the drug have been reported. However, inform your physician or pharmacist about any adverse effects not described in this leaflet.
The expiry date stated on the packaging refers to the product in its original, unopened packaging, correctly stored.
Store below 25 °C.
Caution: do not use the medicine after the expiry date stated on the packaging